Vai direttamente al contenuto

Ostetricia

Gestione e ottimizzazione dell’emostasi

Farmaci antifibrinolitici

Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (apre una nuova finestra)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Fonte‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indicizzato‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (apre una nuova finestra)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (apre una nuova finestra)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Fonte‎: Lancet 2018;391(10116):125-32.

Indicizzato‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (apre una nuova finestra)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (apre una nuova finestra)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Fonte‎: Am J Perinatol 2013;30(5):407-13.

Indicizzato‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (apre una nuova finestra)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (apre una nuova finestra)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Fonte‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indicizzato‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (apre una nuova finestra)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (apre una nuova finestra)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Fonte‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indicizzato‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (apre una nuova finestra)

Fattore VII attivato ricombinante (rFVIIa)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (apre una nuova finestra)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Fonte‎: Obstet Gynecol 2007;110(6):1270-8.

Indicizzato‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (apre una nuova finestra)

The use of recombinant activated FVII in postpartum hemorrhage. (apre una nuova finestra)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Fonte‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indicizzato‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (apre una nuova finestra)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (apre una nuova finestra)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Fonte‎: J Perinat Med 2011;40(1):43-9.

Indicizzato‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (apre una nuova finestra)

Postpartum hemorrhage: when uterotonics and sutures fail. (apre una nuova finestra)

James AH, McLintock C, Lockhart E.

Fonte‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indicizzato‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (apre una nuova finestra)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (apre una nuova finestra)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Fonte‎: J Thromb Haemost 2015;13(4):520-9.

Indicizzato‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (apre una nuova finestra)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (apre una nuova finestra)

Lim Y, Loo CC, Chia V, Fun W.

Fonte‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indicizzato‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (apre una nuova finestra)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (apre una nuova finestra)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Fonte‎: Br J Haematol 2001;114(1):174-6.

Indicizzato‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (apre una nuova finestra)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (apre una nuova finestra)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Fonte‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indicizzato‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (apre una nuova finestra)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (apre una nuova finestra)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Fonte‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indicizzato‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (apre una nuova finestra)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (apre una nuova finestra)

Pepas LP, Arif-Adib M, Kadir RA.

Fonte‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indicizzato‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (apre una nuova finestra)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (apre una nuova finestra)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Fonte‎: Anesth Analg 2009;109(6):1908-15.

Indicizzato‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (apre una nuova finestra)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (apre una nuova finestra)

Prosper SC, Goudge CS, Lupo VR.

Fonte‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indicizzato‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (apre una nuova finestra)

Concentrati di fattori della coagulazione

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (apre una nuova finestra)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Fonte‎: Transfus Med 2012;22(5):344-9.

Indicizzato‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (apre una nuova finestra)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (apre una nuova finestra)

Bell SF, Rayment R, Collins PW, Collis RE.

Fonte‎: Int J Obstet Anesth 2010;19(2):218-23.

Indicizzato‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (apre una nuova finestra)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (apre una nuova finestra)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Fonte‎: Br J Anaesth 2012;108(6):984-9.

Indicizzato‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (apre una nuova finestra)

Desmopressina

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (apre una nuova finestra)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Fonte‎: Haemophilia 2012;18(1):25-33.

Indicizzato‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (apre una nuova finestra)

Farmaci emostatici topici

Tisseel for management of traumatic postpartum haemorrhage. (apre una nuova finestra)

Dhulkotia JS, Alazzam M, Galimberti A.

Fonte‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indicizzato‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (apre una nuova finestra)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (apre una nuova finestra)

Moriarty KT, Premila S, Bulmer PJ.

Fonte‎: BJOG 2008;115(6):793-5.

Indicizzato‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (apre una nuova finestra)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (apre una nuova finestra)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Fonte‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indicizzato‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (apre una nuova finestra)

Fibrin sealant for management of complicated obstetric lacerations. (apre una nuova finestra)

Whiteside JL, Asif RB, Novello RJ.

Fonte‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indicizzato‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (apre una nuova finestra)

Test viscoelastici per individuare un sanguinamento dovuto a intervento chirurgico o coagulopatia

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (apre una nuova finestra)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Fonte‎: Int J Obstet Anesth 2011;20(4):293-8.

Indicizzato‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (apre una nuova finestra)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (apre una nuova finestra)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Fonte‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indicizzato‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (apre una nuova finestra)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (apre una nuova finestra)

Solomon C, Collis RE, Collins PW.

Fonte‎: Br J Anaesth 2012;109(6):851-63.

Indicizzato‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (apre una nuova finestra)